NCT00266006View on ClinicalTrials.gov

Factor VIIa in Acute Intracerebral Haemorrhage

PHASE2CompletedINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions

Acquired Bleeding DisorderIntracerebral Haemorrhage

Interventions

DRUG

eptacog alfa (activated)

Trial Locations (1)

1000005

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY